We are live on ! Find out more
HP

Harbourvest Partners Portfolio holdings

AUM $101M
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
-31.81%
1 Year Est. Return
-38.13%
3 Year Est. Return
-6.18%
5 Year Est. Return
-50.73%
10 Year Est. Return
+34.53%
AUM
$490M
AUM Growth
-$293M
Cap. Flow
-$5.36M
Cap. Flow %
-1.09%
Top 10 Hldgs %
74.75%
Holding
77
New
10
Increased
1
Reduced
3
Closed
11

Top Sells

Rank Stock Value
1
MNDY icon
monday.com
MNDY
+$65.6M
2
TEAD
Teads Holding Co
TEAD
+$22.7M
3
TOST icon
Toast
TOST
+$9.64M
4
TMDX icon
Transmedics
TMDX
+$2.23M
5
FULC icon
Fulcrum Therapeutics
FULC
+$699K

Sector Composition

Rank Sector Weight
1 Technology 45.9%
2 Consumer Discretionary 29.69%
3 Healthcare 15.46%
4 Communication Services 3.24%
5 Industrials 2.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PINS icon
51
Pinterest
PINS
$13.4B
$524K 0.11%
21,310
CPNG icon
52
Coupang
CPNG
$29.3B
$474K 0.1%
+26,834
New +$573K
OPEN icon
53
Opendoor
OPEN
$3.64B
$404K 0.08%
48,264
ROOT icon
54
Root
ROOT
$857M
$402K 0.08%
11,351
MCRB icon
55
Seres Therapeutics
MCRB
$46.8M
$351K 0.07%
2,468
VCTR icon
56
Victory Capital Holdings
VCTR
$6.19B
$346K 0.07%
+11,978
New +$391K
DCT
57
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
$321K 0.07%
14,508
DASH icon
58
DoorDash
DASH
$85.5B
$294K 0.06%
2,505
LOV
59
DELISTED
Spark Networks SE American Depositary Shares
LOV
$281K 0.06%
104,228
PMVP icon
60
PMV Pharmaceuticals
PMVP
$59.2M
$240K 0.05%
11,533
PACB icon
61
Pacific Biosciences
PACB
$435M
$214K 0.04%
23,484
IPSC icon
62
Century Therapeutics
IPSC
$364M
$184K 0.04%
14,631
RPTX
63
DELISTED
Repare Therapeutics
RPTX
$175K 0.04%
12,276
OYST
64
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$146K 0.03%
12,560
NXTC icon
65
NextCure
NXTC
$16.8M
$49K 0.01%
837
ALGS icon
66
Aligos Therapeutics
ALGS
$26.2M
$40K 0.01%
751
BLND icon
67
Blend Labs
BLND
$431M
-33,128
Closed -$243K
CTMX icon
68
CytomX Therapeutics
CTMX
$675M
-79,193
Closed -$343K
CVRX icon
69
CVRx
CVRX
$137M
-5,396
Closed -$66K
DAWN
70
DELISTED
Day One Biopharmaceuticals
DAWN
-13,388
Closed -$226K
FULC icon
71
Fulcrum Therapeutics
FULC
$239M
-39,511
Closed -$699K
METC icon
72
Ramaco Resources Class A
METC
$599M
-30,471
Closed -$401K
TEAD
73
Teads Holding Co
TEAD
$68.7M
-1,620,000
Closed -$22.7M
TMDX icon
74
Transmedics
TMDX
$2.64B
-116,123
Closed -$2.23M
KA
75
DELISTED
Kineta, Inc. Common Stock
KA
-3,147
Closed -$65K

Similar funds

Harbourvest Partners's Q1 2022 Portfolio in Review

As of Q1 2022, Harbourvest Partners held 77 positions worth $490M, down 37% from $782M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Harbourvest Partners's Q1 2022 filing shows 10 new, 1 increased, 3 reduced and 11 closed positions. Its largest new stake was AvidXchange: 3,387,791 shares worth $27.3M. The largest sale was monday.com, an estimated $65.6M.

By sector, the portfolio is most concentrated in Technology at 46% of assets, down from 50% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Harbourvest Partners's largest Q1 2022 buy was AvidXchange: 3,387,791 shares worth $27.3M.
  • Harbourvest Partners added most to Axcella Health Inc. Common Stock in Q1 2022, an estimated $3.14M increase.
  • Harbourvest Partners's biggest Q1 2022 reduction was monday.com, cutting an estimated $65.6M.
  • Harbourvest Partners fully exited Teads Holding Co in Q1 2022, selling an estimated $22.7M.
  • Harbourvest Partners's ten largest holdings make up 75% of its $490M portfolio in Q1 2022.
  • Harbourvest Partners opened 10 new positions and closed 11 in Q1 2022.
  • Harbourvest Partners's portfolio value fell 37% quarter-over-quarter to $490M.

Based on Harbourvest Partners's 13F filing for Q1 2022, filed 13 May 2022.